ATROPHY OF TONGUE PAPILLAE

This adverse event was reported 15 times

ATROPHY OF TONGUE PAPILLAE is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 LOPINAVIR AND RITONAVIR 3 0.0002
1 LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE 2 0.0000
2 LIDOCAINE HYDROCHLORIDE 2 0.0000
3 LAMOTRIGINE 4 0.0000
4 ANASTROZOLE 1 0.0000
5 CAPECITABINE 2 0.0000
6 RIBAVIRIN 1 0.0000
7 FLUOXETINE HYDROCHLORIDE 2 0.0000
8 ZOLPIDEM TARTRATE 2 0.0000
9 CLONAZEPAM 2 0.0000
See all drugs enriched for association with ATROPHY OF TONGUE PAPILLAE

ATROPHY OF TONGUE PAPILLAE is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Protease Inhibitor [EPC] 3 0.0001
1 Cytochrome P450 3A Inhibitor [EPC] 3 0.0000
2 Mood Stabilizer [EPC] 4 0.0000
3 Anti-epileptic Agent [EPC] 4 0.0000
4 Nucleoside Analog Antiviral [EPC] 1 0.0000
5 Aromatase Inhibitor [EPC] 1 0.0000
6 Nucleoside Metabolic Inhibitor [EPC] 2 0.0000
7 Platinum-based Drug [EPC] 1 0.0000
8 Vitamin D [EPC] 1 0.0000
9 Angiotensin 2 Receptor Blocker [EPC] 1 0.0000
See all drug classes enriched for association with ATROPHY OF TONGUE PAPILLAE